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Abstract
Background: Pelvic organ prolapse (POP) is a condition affecting more than half of the women above age 40. The
estimated lifetime risk of needing surgical management for POP is 11%.
In patients undergoing POP surgery of the anterior vaginal wall, the re-operation rate is 30%. The recurrence risk is
especially high in women with a levator ani defect. Such defect is present if there is a partially or completely
detachment of the levator ani from the inferior ramus of the symphysis. Detecting levator ani defects is relevant
for counseling, and probably also for treatment. Levator ani defects can be imaged with MRI and also with
Translabial 3D ultrasonography of the pelvic floor.
The primary aim of this study is to assess the diagnostic accuracy of translabial 3D ultrasonography for diagnosing
levator defects in women with POP with Magnetic Resonance Imaging as the reference standard. Secondary goals
of this study include quantification of the inter-observer agreement about levator ani defects and determining the
association between levator defects and recurrent POP after anterior repair. In addition, the cost-effectiveness of
adding translabial ultrasonography to the diagnostic work-up in patients with POP will be estimated in a decision
analytic model.
Methods/Design: A multicentre cohort study will be performed in nine Dutch hospitals. 140 consecutive women
with a POPQ stage 2 or more anterior vaginal wall prolapse, who are indicated for anterior colporapphy will be
included. Patients undergoing additional prolapse procedures will also be included.
Prior to surgery, patients will undergo MR imaging and translabial 3D ultrasound examination of the pelvic floor.
Patients will be asked to complete validated disease specific quality of life questionnaires before surgery and at six
and twelve months after surgery. Pelvic examination will be performed at the same time points.
Assuming a sensitivity and specificity of 90% of 3D ultrasound for diagnosing levator defects in a population of
120 women with POP, with a prior probability of levator ani defects of 40%, we will be able to estimate predictive
values with good accuracy (i.e. confidence limits of at most 10% below or above the point estimates of positive
and negative predictive values).
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Anticipating 3% unclassifiable diagnostic images because of technical reasons, and a further safety margin of 10%
we plan to recruit 140 patients.
Trial registration: Nederlands trial register NTR2220.
Background
Pelvic organ prolapse (POP) is a condition affecting
more than half of the women above age 40 [1]. The esti-
mated lifetime risk of needing surgical management for
pelvic organ prolapse is 11% [2].
In the Netherlands yearly 13,000 patients undergo sur-
gical correction for POP [3]. These operations are
known to have a re-operation rate of up to 30% because
of primary failure or secondary recurrence of signs and
symptoms of POP [2]. Because of this high re-operation
rate, prolapse recurrence after pelvic floor surgery con-
stitutes a major health care problem. Therefore identify-
ing patients with an individual higher risk for
recurrence of POP after surgery can possibly lead to
individualized counseling and choice of treatment and
possibly to reduction of the proportion of re-operations.
Several risk factors associated with surgical failure
have been investigated in a number of studies.
Cystocele is the most commonly affected compart-
ment in pelvic organ prolapse and is also the most
prone for recurrence after surgery [4,5]. Younger
women and women with a more advanced prolapse, a
previous hysterectomy, and vaginal childbirth are at an
increase risk of prolapse recurrence after surgery [6-9].
Recently, using Magnetic Resonance Imaging (MRI),
trauma to the levator ani muscle has been shown to be
a common consequence of vaginal delivery [10-12],
affecting 20-30% of parous women as compared to 0%
in nulliparous women [13]. Trauma to the levator ani
muscle generally seems to manifest as a partial or com-
plete detachment of the levator ani from the inferior
ramus of the symphysis. [14]. A relationship has been
established between levator defects and POP. This at
least partly explains the link between vaginal childbirth
and POP, and possibly also with POP recurrence after
surgery [15,16].
In a population of urogynecological patients, women
with levator defects postpartum were about twice as
likely to show POP stage II or higher - especially cysto-
cele and uterine prolapse - as those with an intact leva-
tor muscle, [15]. In a general population, women with
POP appeared to have more levator defects than con-
trols without POP (55% compared to 16%) [17].
In a previous study we showed anatomical recurrence
of cystocele was associated with major levator defects
with an odds ratio of 2.5 (95% confidence interval (CI)
1.1-5.7, p = 0.03) [18]. Dietz et al reported an even stron-
ger association (OR 7.0, 95% CI 2.6, 19.1, p < 0.01) [19].
Recent advancements in imaging allow assessment of
the levator ani muscle imaging with 3D pelvic floor
ultrasound, comparing it to MR imaging as the refer-
ence standard. Several studies using MR imaging pelvic
floor ultrasound have demonstrated that levator defects
occur after vaginal birth [10,12,15,17].
Because accurate assessment of pelvic floor injury may
help explain symptoms and potentially guide future
treatment options, it is important to study on imaging
in detecting these levator defects.
Moreover using 3D pelvic ultrasound for diagnosing
levator defects is non-invasive, patient friendly, less
expensive and it has practical advantages like shorter
examination time and less exclusion criteria like pros-
thesis, claustrophobia etc compared to MR-imaging.
Translabial 3D-ultrasonography allows imaging of the
levator ani muscle including assessment of its integrity
[11,20]. However until now no accuracy studies have
been published concerning the use of 3D ultrasonogra-
phy to diagnose levator defects. Few publications men-
tion inter-observer variability in diagnosing levator
defects. Steensma and co-workers have conducted a
test-retest series of 50 volume datasets of patients with
pelvic floor dysfunction for diagnosing levator defects to
assess inter-observer reliability, which yielded a Cohen’s
kappa of 0.83 (95% Confidence interval (CI) 0.59,1.0),
meaning excellent agreement [11]. In another study on
grading the size of levator defects, the same research
group has reported moderate agreement between differ-
ent observers reflected in an intraclass correlation coeffi-
cient (ICC) of 0.53 (95% CI 0.13, 0.76) [20].
The main objective of our study is to estimate the
diagnostic accuracy of translabial 3D ultrasonography of
the pelvic floor as compared to MR imaging, the refer-
ence standard, for diagnosing levator defects in women
with POP.
The second aim of this study is to estimate the level
of agreement between observers and determine
whether levator defects are a risk factor for recurrence
after POP surgery. In addition, the cost-effectiveness of
introducing translabial ultrasonography in the work-up
of a patient with POP will be estimated in a decision
analytic model.
Methods/design
Study aims
1. Estimating the diagnostic accuracy of translabial
3D ultrasonography of the pelvic floor as compared
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to MR imaging for diagnosing levator defects in
women with POP.
2. Measuring the inter-observer agreement in diag-
nosing and in grading levator defects with 3D
ultrasonography.
3. Measuring the association between levator defects
and recurrent POP after anterior repair.
4. Evaluating potential cost-effectiveness of introdu-
cing 3D ultrasonography for diagnosing levator
defects in the work-up of patients with POP.
Study design
The TRUDIL study is a multicentre cohort study in nine
teaching and non-teaching hospitals in The Netherlands.
Ethical considerations
The study has been approved by the institutional review
board of the Maastricht University Medical Centre, in
Maastricht. Ethical approval for this study was obtained
on 22-02-2010, number 08-2-093. Local approval was
obtained in all participating centers.
Identifying eligible patients
Eligible patients will be identified by gynecologists in
each of the nine participating hospitals in The
Netherlands.
All consecutive women with at least a cystocele POPQ
stage II who are scheduled for conventional anterior col-
porrhaphy alone or in combination with other POP sur-
gery, without the use of mesh-materials, will be asked to
participate in this study. Patients will be excluded in
case of previous POP or incontinence surgery, in case of
planned surgery with mesh materials, or in case of POP
surgery in combination with incontinence surgery.
Women with a contra-indication for undergoing MR
imaging will also be excluded [see Figure 1].
All eligible patients will receive an information sheet
about this study from their attending gynecologist.
About one week after counseling has taken place, a
research nurse or the gynecologist will call the patient
to check for any upcoming questions about the study
and her willingness to participate. If the patient is will-
ing to participate, informed consent will be signed. The
patient and the attending gynecologist will not be
informed on the findings in the study until the study
has been finished, therefore these findings do not affect
the choice of treatment for these women.
Interventions
Diagnostic work-up
Of each patient, baseline characteristics will be recorded.
Participants will be interviewed and examined for pro-
lapse by their attending gynecologist. POP will be staged
according to the POPQ staging system of the Interna-
tional Continence Society [21].
All patients will undergo MR imaging and 3D ultraso-
nography before surgery takes place. The assessment of
3D ultrasound and MR-imaging of the levator ani mus-
cle will be performed by experienced observers who
have performed and assessed more than hundred 3D
translabial ultrasounds or pelvic floor MR images before
the start of the study.
All images will be stored according to a detailed pro-
tocol [see Additional files 1 and 2].
3D-ultrasound will be performed after emptying the
bladder. 3D ultrasonographic volume data sets will be
collected and stored. Afterwards, all volumes will be
interpreted independently offline by two examiners who
are blinded to the associated clinical data. If disagree-
ment exists, an expert panel, which consist of three
trained gynecologists, will decide on a final conclusion
in a consensus meeting.
For reading the MR-images the same protocol will be
followed. Images will be interpreted by two independent
examiners and if disagreement exists consensus will be
reached by three trained radiologists in a consensus
meeting. The radiologists and the gynecologist are also
blinded for each others assessment.
Follow-up
Case record forms on the surgical data and complica-
tions will be completed. Follow-up appointments will be
made six weeks, six months and twelve months post-
operatively. At these measurement time points a physi-
cal examination for staging POP will be performed by
an independent examiner to diagnose any anatomical
recurrence. Validated Quality of Life and subjective feel-
ings of recurrence questionnaires will be handed out
before the surgery takes place and at six and twelve
months after the surgery (EuroQol-5D, patient global
impression of severity/improvement). For all these visits
case record forms will be completed.
Inclusion criteria:
The patient has at least a POPQ stage II descent of the anterior compartment
The patient is scheduled for colporraphia anterior alone or in combination with other 
       POP surgery
Exclusion criteria:
Previous POP surgery
If there is the intention to use mesh- materials
Previous incontinence surgery or planned additional incontinence 
surgery (TVT,TOT etc)
Contra indications for MR-imaging (e.g pace-maker, artificial valves, prosthesis).
Figure 1 Study inclusion and exclusion criteria.
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Outcome measures
Primary outcome
The diagnostic test performance of translabial 3D ultra-
sonography as compared to MR imaging in detecting
levator defects.
Secondary outcomes
1. Measuring the inter-observer agreement in diag-
nosing and in grading levator defects with 3D
ultrasonography.
2. Measuring the association between levator defects
and recurrent POP after anterior repair.
3. Evaluating potential cost-effectiveness of introdu-
cing 3D ultrasonography for diagnosing levator
defects in the work-up of patients with POP.
Data collection
The data will be recorded in a web based registry. Parti-
cipants receive a case number to treat their data anon-
ymously and to blind the observers. The observers are
also blinded to all ultrasonography, MR-imaging data
and clinical data. The patient and the attending gynecol-
ogist will not be informed of the findings in the study
until the study has been finished.
Sample size consideration
Ultrasound studies describe a prevalence of 20-40% of
levator defects in patients with POP [15,17]. One MRI
study detected levator defects in 55% of the women with
POP. Calculating a sample size for the diagnostic test
characteristics is complicated by the fact that only a few
studies have been published about reproducibility of 3D
ultrasound and in this study no other test characteristics
were given. Assuming a sensitivity and specificity of 90%
of 3D ultrasound for diagnosing levator defects in a
population of 120 women with POP, with a prevalence
of levator ani defects of 40%, we will be able to estimate
predictive values with an accuracy of 10% below or
above the point estimate of positive predictive values
and negative predictive values.
Including 120 patients yields at least 80% to demon-
strate that inter-observer agreement is substantial (Kappa
>= 0.61), using a 0.05 significance level in one-sided test-
ing, while expecting a 40% prevalence of levator defects
and anticipating a value of the kappa statistic of 0.78 or
better. In order to be able to detect a difference in recur-
rence rate after anterior colporrhaphy of 25% or more
(35% in women with a levator defect vs 10% in women
without levator defect), with an alpha of 5% and a power
of 80%, a population of 102 patients with at least POPQ
stage II prolapse in the anterior compartment, of whom
41 (40%) women with a levator defect, will be sufficient.
We are aiming to include 140 patients in this study,
taking into consideration 3% technical problems in per-
forming 3D-ultrasonography or MR imaging, which can
result in non-evaluable images, and a further safety mar-
gin of 10%.
Economic evaluation
Potential cost-effectiveness of translabial 3D ultrasound
in the diagnostic work-up of a patient with POP to diag-
nose levator defects in order to identify patients at risk
for recurrence, and subsequent adjustments of the type
of surgery, will be determined by comparing diagnostic
strategies. The incremental costs-effectiveness ratio(s)
will be expressed as the incremental costs per recur-
rence avoided. As only part of the data needed to esti-
mate potential cost-effectiveness of the 3D ultrasound
will be collected empirically, a decision analytic model
will be constructed [22,23]. The comparative sensitivity,
specificity and costs of 3D ultrasound versus MR ima-
ging for the diagnostic work-up of patients with POP
will explicitly be incorporated in the model. The cost
analysis will be performed from a hospital perspective,
according to Dutch guidelines and will be estimated
from study entry to twelve months follow up [24].
Statistical analysis
Accuracy of 3D ultrasonography for diagnosing levator
defects will be expressed in terms of sensitivity, specifi-
city, standardized predictive values and their 95% -confi-
dence interval. For the calculation of 95%-confidence
intervals the Wilson formula for proportions will be
used. ROC analysis will be performed for the grading of
the size of levator defects with 3D ultrasound. Inter-
observer and intra-observer agreement of diagnosing
levator defects with 3D ultrasound will be evaluated by
means of Cohen’s Kappa coefficient and intra class coef-
ficient. Logistic regression will be performed to deter-
mine whether levator defects constitute an independent
risk factor for recurrence after POP surgery.
Time plan
Patient recruitment started in March 2010 and is planned
to continue until June 2011. The follow-up period is 12
months and therefore will continue until June 2012.
This study is conducted in cooperation with several
centers collaborating in the Dutch Urogynecology
Research Consortium. Most participating hospitals have
a research nurse, who contributes to the counseling of
the patient and the web-based data collection.
Knowledge transfer
The outcome of this study will be important for the debate
on the value of 3D ultrasound of the pelvic floor in a
patient with pelvic organ prolapse for detecting levator
defects. If the diagnostic accuracy of 3D ultrasonography
in diagnosing levator defects and the clinical relevance of
levator defects in this study will be confirmed, further
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implementation into guidelines and training of urogyne-
cologists and ultrasonographers will be taken care of. It is
also important to inform gynecologists if this relevance
cannot be confirmed, if only to prevent any treatment
based on a technique that is not relevant or accurate
enough. The results of this study will be presented at
national and international scientific meetings, and will be
published in international scientific journals.
Additional material
Additional file 1: Protocol Ultrasound.
Additional file 2: Protocol MR imaging.
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